Belpointe Asset Management LLC Takes $528,000 Position in VanEck Pharmaceutical ETF $PPH

Belpointe Asset Management LLC acquired a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 5,797 shares of the company’s stock, valued at approximately $528,000. Belpointe Asset Management LLC owned about 0.08% of VanEck Pharmaceutical ETF at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of PPH. Bank of America Corp DE increased its position in shares of VanEck Pharmaceutical ETF by 5.2% during the 4th quarter. Bank of America Corp DE now owns 109,237 shares of the company’s stock valued at $9,425,000 after purchasing an additional 5,447 shares during the last quarter. Cetera Investment Advisers grew its position in VanEck Pharmaceutical ETF by 2.7% during the 4th quarter. Cetera Investment Advisers now owns 37,796 shares of the company’s stock worth $3,261,000 after acquiring an additional 983 shares during the last quarter. Focus Partners Wealth purchased a new position in VanEck Pharmaceutical ETF in the 4th quarter worth approximately $243,000. Two Sigma Investments LP bought a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $12,482,000. Finally, Investment Management Corp VA ADV bought a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $458,000.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH stock opened at $89.07 on Friday. The stock has a 50 day moving average price of $87.43 and a two-hundred day moving average price of $87.87. VanEck Pharmaceutical ETF has a fifty-two week low of $77.67 and a fifty-two week high of $98.30. The company has a market capitalization of $484.54 million, a P/E ratio of 20.21 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, July 7th. Stockholders of record on Tuesday, July 1st were paid a $0.6069 dividend. This represents a $2.43 annualized dividend and a dividend yield of 2.7%. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Tuesday, July 1st.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.